On July 3, 2026, Anurita Bains, UNICEF Associate Director for HIV and Health, warned that the global AIDS response is at a critical juncture following significant funding cuts in 2025. These cuts have jeopardized years of progress in combating HIV, particularly in high-burden countries across Africa and parts of Asia.
Impact of Funding Cuts on HIV Treatment
Over the past decade, there has been a remarkable decrease in AIDS-related deaths among children, dropping by nearly 70%. However, abrupt funding reductions have stalled prevention efforts, leading to stockouts of essential medicines and the layoff of health workers. The implications are dire; if funding and treatment coverage are not restored, up to 3 million children could be newly infected with HIV by 2040.
Leaders at the United Nations High-Level Meeting on HIV/AIDS emphasized that the world is facing a “perilous moment.” The disruptions have also spotlighted widening inequalities in treatment access, particularly for pregnant women in West and Central Africa and marginalized communities throughout Latin America and the Caribbean.
Innovations and Community Engagement
Despite these challenges, there are promising innovations and community-led solutions that can still turn the tide. Breakthroughs like lenacapavir, a long-acting prevention option requiring only two injections a year, have the potential to significantly improve access for adolescent girls and young women. Such advancements can also benefit pregnant and breastfeeding women, ensuring protection for both mothers and their babies.





